Partial sequencing and tissue distribution of the canine isoforms of steroid 5α-reductase type I and type II

Prostate

Volumn 44, Issue 3, 2000, Pages 233-239

  Span, P N ^a   Van Bokhoven, A ^a   Smals, A G H ^a   Sweep, C G J ^a   Schalken, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Androgens; Dog prostate; Isoenzymes; Steroids

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; MESSENGER RNA; NUCLEOTIDE; PROTEIN; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; DNA SEQUENCE; DOG; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROID METABOLISM; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONING, MOLECULAR; DNA; DNA PRIMERS; DOGS; ELECTROPHORESIS, AGAR GEL; ISOENZYMES; MALE; MOLECULAR SEQUENCE DATA; PROSTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SCINTILLATION COUNTING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0034255953     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(20000801)44:3<233::AID-PROS8>3.0.CO;2-C     Document Type: Article

References (37)

1. Wilson JD. The pathogenesis of benign prostatic hyperplasia. Am J Med 1980;68:745-756.
2. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS, Vaughan ED, Pappas F, Taylor A, Binkowitz B, Ng J, The Finasteride Study Group. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992;327:1185-1191.
3. Russell DW, Wilson JD. Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 1994;63:25-61.
4. Isaacs JT. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle. J Steroid Biochem 1983;18:749-757.
5. Lowseth LA, Gerlach RF, Gillett NA, Muggenburg BA. Age-related changes in the prostate and testes of the beagle dog. Vet Pathol 1990;27:347-353.
6. Zirkin BR, Strandberg JD. Quantitative changes in the morphology of the aging canine prostate. Anat Rec 1984;208:207-214.
7. Brendler CB, Berry SJ, Ewing LL, McCullough AR, Cochran RC, Strandberg JD, Zirkin BR, Coffey DS, Wheaton LG, Hiler ML, Niswender GD, Bordy MJ, Shaper JH, Scott WW, Walsh PC. Spontaneous benign prostatic hyperplasia in the beagle: the relationships between age, serum hormone levels, and the morphology and function of the canine prostate. J Clin Invest 1983; 71:1-10.
8. Gloyna R, Siiteri PK, Wilson JD. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J Clin Invest 1970;49:1746-1753.
9. Cohen SM, Werrmann JG, Rasmusson GH, Tanaka WK, Malatesta PF, Prahalada S, Jacobs JG, Harris G, Nett TM. Comparison of the effects of new specific azasteroid inhibitors of steroid 5α-reductase on canine hyperplastic prostate: suppression of prostate DHT correlated with prostate regression. Prostate 1995; 26:55-71.
10. Brooks JR, Berman C, Glitzer MS, Gordon LR, Primka RL, Reynolds GF, Rasmusson GH. Effect of a new 5α-reductase inhibitor on size, histological characteristics, and androgen concentrations of the canine prostate. Prostate 1982;3:35-44.
11. Juniewicz PE, Hoekstra SJ, Lemp BM, Barbolt TA, Devin JA, Gauthier E, Frenette G, Dube JY, Tremblay RR. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5α-reductase inhibitor, on the prostate and testes of beagle dogs. Endocrinology 1993;133:904-913.
12. Cohen SM, Taber KH, Malatesta PF, Shpungin J, Berman C, Carlin JR, Werrmann JG, Prahalada S, Bryan RN, Cordes EH. Magnetic resonance imaging of the efficacy of specific inhibition of 5α-reductase in canine spontaneous benign prostatic hyperplasia. Magn Reson Med 1991;21:55-70.
13. Brooks JR, Berman C, Garnes D, Giltinan D, Gordon LR, Malatesta PF, Primka RL, Reynolds GF, Rasmusson GH. Prostatic effect induced in dogs by chronic or acute oral administration of 5α-reductase inhibitors. Prostate 1986;9:65-75.
14. Laroque PA, Prahalada S, Gordon LR, Molon Noblot S, Bagdon WJ, Duprat P, Peter CP, Van Zwieten MJ. Effects of chronic oral administration of a selective 5α-reductase inhibitor, finasteride, on the dog prostate. Prostate 1994;24:93-100.
15. Häusler A, Allegrini PR, Biollaz M, Batzl C, Sheidegger E, Bhatnagar AS. CGP 53153: a new potent inhibitor of 5α-reductase. J Steroid Biochem Mol Biol 1996;57:187-195.
16. Wenderoth UK, George FW, Wilson JD. The effect of a 5α-reductase inhibitor on androgen-mediated growth of the dog prostate. Endocrinology 1983;113:569-573.
17. Di Salle E, Briatico G, Giudici D, Ornati G, Panzeri A. Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073). J Steroid Biochem Mol Biol 1994;48:241-248.
18. Sun ZY, Feng J, Qi XD, Wu HY, Zheng WJ, Tu ZH. Reversible long-term toxicity of epristeride in beagle dogs. Toxicol Appl Pharmacol 1999;154:145-152.
19. Span PN, Schalken JA, Sweep CGJ, Smals AG. Identification and partial characterization of two steroid 5α-reductase isozymes in the canine prostate. Prostate 1998;34:222-230.
20. Liang T, Cascieri MA, Cheung AH, Reynolds GF, Rasmusson GH. Species differences in prostatic steroid 5α-reductases of rat, dog, and human. Endocrinology 1985;117:571-579.
21. Prins GS, Jung MH, Vellanoweth RL, Chatterjee B, Roy AK. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev Genet 1996;18:99-106.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193: 265-275.
23. Ellsworth KP, Azzolina BA, Cimis G, Bull HG, Harris GS. Cloning, expression and characterization of rhesus macaque types 1 and 2 5α-reductase: evidence for mechanism-based inhibition by finasteride. J Steroid Biochem Mol Biol 1998;66:271-279.
24. Levy MA, Brandt M, Sheedy KM, Holt DA, Heaslip JI, Trill JJ, Ryan PJ, Morris RA, Garrison LM, Bergsma DJ. Cloning, expression and functional characterization of type 1 and type 2 steroid 5α-reductases from Cynomolgus monkey: comparisons with human and rat isoenzymes. J Steroid Biochem Mol Biol 1995;52: 307-319.
25. Anwar R, Gilbey SG, New JP, Markham AF. Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5α-reductase type 2 gene (SRD5A2). Mol Pathol 1997;50: 51-52.
26. Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zollner A, Struve D. Nonisotopic single strand conformation analysis of the 5α-reductase type 2 gene for the diagnosis of 5α-reductase deficiency. J Clin Endocrinol Metab 1996;81:3415-3418.
27. Canto P, Vilchis F, Chavez B, Mutchinick O, Imperato-McGinley J, Perez-Palacios G, Ulloa-Aguirre A, Mendez JP. Mutations of the 5α-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5α-reductase-2 deficiency. Clin Endocrinol (Oxf) 1997;46:155-160.
28. Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase 2 deficiency. Endocr Rev 1993;14:577-593.
29. Wigley WC, Prihoda JS, Mowszowicz I, Mendonca BB, New MI, Wilson JD, Russell DW. Natural mutagenesis study of the human steroid 5α-reductase 2 isozyme. Biochemistry 1994;33: 1265-1270.
30. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 1993;92:903-910.
31. Normington K, Russell DW. Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes. Evidence for distinct physiological functions. J Biol Chem 1992;267:19548-19554.
32. Poletti A, Martini L. Androgen-activating enzymes in the central nervous system. J Steroid Biochem Mol Biol 1999;69:117-122.
33. McDermott M, Latif S, Morris DJ. The metabolism of aldosterone in kidney. J Steroid Biochem 1983;19:1205-1211.
34. Matsuzaki K, Arai T, Inumaru T, Mihori M, Momose T, Sano M, Koide K, Shimizu N. Androgen metabolism in cultured rat renal inner medullary collecting duct (IMCD) cells. Steroids 1998;63: 105-110.
35. Levy MA, Brandt M, Sheedy KM, Dinh JT, Holt DA, Garrison LM, Bergsma DJ, Metcalf BW. Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α-reductase isoform 2. J Steroid Biochem Mol Biol 1994;48:197-206.
36. Andersson S, Russell DW. Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci USA 1990;87:3640-3644.
37. Span PN, Benraad TJ, Sweep CG, Smals AG. Kinetic analysis of steroid 5α-reductase activity at neutral pH in benign prostatic hyperplastic tissue: evidence for type I isozyme activity in the human prostate. J Steroid Biochem Mol Biol 1996;57:103-108.